secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001837607-25-000032
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NYSE American accepts AEON's compliance plan; delisting risk deferred to Aug 2026
--------------------------------------------------------------------------------

- NYSE American accepted AEON's compliance plan on April 22, 2025, granting until August 3, 2026 to meet listing standards under Sections 1003(a)(i)-(iii).
- AEON remains listed on NYSE American under symbol AEON during the Plan Period, subject to periodic progress reviews.
- Failure to regain compliance or make sufficient progress by August 3, 2026 may lead to delisting proceedings.
- Non-compliance was first disclosed in February 2025; plan submission deadline was March 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000032/0001837607-25-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760725000032/aeon-20250422x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-25-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer